Global SYMPLICITY Registry Locations and Inclusion Criteria a,b
description
Transcript of Global SYMPLICITY Registry Locations and Inclusion Criteria a,b
Global SYMPLICITY RegistryLocations and Inclusion Criteriaa,b
SYMPLICITY RegistryMajor Adverse Events
SYMPLICITY RegistryChange in Office SBP
SYMPLICITY RegistryHigh Baseline BP Subset
SYMPLICITY RegistryDesign Implications for Clinical Practicea,b
Treatment Effectiveness in RDNResponse Assessment
SYMPLICITY RegistryPredictors of RDN Response
Number and Types of Comorbidities
RDN Response
Biomarkers of RDN Effectiveness Current and Future Directions
SYMPLICITY HTN-3Resultsa,b
SYMPLICITY HTN-3Subgroup Analyses
SYMPLICITY HTN-3Medication Changesa
SYMPLICITY HTN-3 Medication Types
SYMPLICITY HTN-3Medication Types (cont)a
SYMPLICITY HTN-3African-American Population
SYMPLICITY HTN-3African-American Population
(cont)a
SYMPLICITY HTN-3African-American Population
(cont)a
SYMPLICITY HTN-3 Procedural Effects – No. of Ablations
SYMPLICITY HTN-3Procedural Effects – Circumferentiality
Other RDN Procedural Factors
ConclusionsRDN Moving Forward
Abbreviations
References
References (cont)
References (cont)
References (cont)